These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2339695)

  • 21. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
    Kadler KE; Torre-Blanco A; Adachi E; Vogel BE; Hojima Y; Prockop DJ
    Biochemistry; 1991 May; 30(20):5081-8. PubMed ID: 2036375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.
    Byers PH; Tsipouras P; Bonadio JF; Starman BJ; Schwartz RC
    Am J Hum Genet; 1988 Feb; 42(2):237-48. PubMed ID: 3341380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
    Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
    Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta.
    Tsipouras P; Børresen AL; Dickson LA; Berg K; Prockop DJ; Ramirez F
    Am J Hum Genet; 1984 Nov; 36(6):1172-9. PubMed ID: 6097110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Bonadio J; Byers PH
    Nature; 1985 Jul 25-31; 316(6026):363-6. PubMed ID: 4022126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
    Oliver JE; Thompson EM; Pope FM; Nicholls AC
    Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    de Wet WJ; Pihlajaniemi T; Myers J; Kelly TE; Prockop DJ
    J Biol Chem; 1983 Jun; 258(12):7721-8. PubMed ID: 6863261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta.
    Galicka A; Wolczyñski S; Anchim T; Surazyñski A; Lesniewicz R; Palka J
    Eur J Biochem; 2001 Apr; 268(7):2172-8. PubMed ID: 11277941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta.
    Dyne K; Cetta G; Tenni R; Rossi A; Finardi E; Brunelli PC; Castellani AA
    Ital J Biochem; 1987; 36(4):256-66. PubMed ID: 3429209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
    Nicholls AC; Osse G; Schloon HG; Lenard HG; Deak S; Myers JC; Prockop DJ; Weigel WR; Fryer P; Pope FM
    J Med Genet; 1984 Aug; 21(4):257-62. PubMed ID: 6492090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of osteogenesis imperfecta and related disorders of bone.
    Prockop DJ; Kuivaniemi H; Tromp G
    Clin Plast Surg; 1994 Jul; 21(3):407-13. PubMed ID: 7924138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.
    Tenni R; Biglino P; Dyne K; Rossi A; Filocamo M; Pendola F; Brunelli P; Buttitta P; Borrone C; Cetta G
    J Inherit Metab Dis; 1991; 14(2):189-201. PubMed ID: 1886404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
    Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta.
    Dickson LA; Pihlajaniemi T; Deak S; Pope FM; Nicholls A; Prockop DJ; Myers JC
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4524-8. PubMed ID: 6087329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies.
    Prockop DJ; Colige A; Helminen H; Khillan JS; Pereira R; Vandenberg P
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S489-92. PubMed ID: 8122517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII.
    Raff ML; Craigen WJ; Smith LT; Keene DR; Byers PH
    Hum Genet; 2000 Jan; 106(1):19-28. PubMed ID: 10982177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.
    Khillan JS; Olsen AS; Kontusaari S; Sokolov B; Prockop DJ
    J Biol Chem; 1991 Dec; 266(34):23373-9. PubMed ID: 1744131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.